Groupe de Recherche et d’Action pour la Santé
Accueil > Europe du médicament > European Medicines Agency and pharmacovigilance : no to a fee-for-service (...)

European Medicines Agency and pharmacovigilance : no to a fee-for-service system

dimanche 11 novembre 2012

On 18 June 2012, the EU Commission published a draft concept paper for public consultation on the “Introduction of fees to be charged by the European Medicines Agency for pharmacovigilance”. Regrettably, the European Medicines Agency (EMA) is being turned into a mere provider of services to the pharmaceutical industry. Other strategies for funding that would help drug regulatory agencies to be more independent do exist. They should be carefully considered...

Voir en ligne : European Medicines Agency and pharmacovigilance : no to a fee-for-service system

SPIP | squelette | | Plan du site | Suivre la vie du site RSS 2.0 | © GRAS asbl 2012